The BCS, BDDCS, and Regulatory Guidances

Author： Chen Mei-Ling   Amidon Gordon   Benet Leslie   Lennernas Hans   Yu Lawrence  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.28, Iss.7, 2011-07, pp. : 1774-1778

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

From Drug Delivery Systems to Drug Release, Dissolution, IVIVC, BCS, BDDCS, Bioequivalence and Biowaivers

By Karalis Vangelis   Magklara Eleni   Shah Vinod   Macheras Panos  

Pharmaceutical Research, Vol. 27, Iss. 9, 2010-09 ,pp. : 2018-2029

Springer Publishing Company

Access to resources Recommend Favorite

Impact of Regulatory Guidances and Drug Regulation on Risk Minimization Interventions in Drug Safety: A Systematic Review

By Nkeng Lenhangmbong   Cloutier Anne-Marie   Craig Camille   Lelorier Jacques   Moride Yola  

Drug Safety, Vol. 35, Iss. 7, 2012-07 ,pp. : 535-546

Adis International

Access to resources Recommend Favorite

UK NICE issues spate of guidances

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 432, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Predicting Intestinal Precipitation—A Case Example for a Basic BCS Class II Drug

By Carlert Sara   Pålsson Anna   Hanisch Gunilla   Corswant Christian   Nilsson Catarina   Lindfors Lennart   Lennernäs Hans   Abrahamsson Bertil  

Pharmaceutical Research, Vol. 27, Iss. 10, 2010-10 ,pp. : 2119-2130

Springer Publishing Company

Access to resources Recommend Favorite

Postprandial Changes in Solubilizing Capacity of Human Intestinal Fluids for BCS Class II Drugs

By Clarysse Sarah   Psachoulias Dimitrios   Brouwers Joachim   Tack Jan   Annaert Pieter   Duchateau Guus   Reppas Christos   Augustijns Patrick  

Pharmaceutical Research, Vol. 26, Iss. 6, 2009-06 ,pp. : 1456-1466

Springer Publishing Company

Access to resources Recommend Favorite